Ostarine (MK-2866): A Tracking Guide for the Most-Studied SARM

Ostarine, known in development as MK-2866 or enobosarm, is generally considered the mildest and most-studied selective androgen receptor modulator (SARM). Under the name enobosarm it has been investigated in genuine clinical trials, including for muscle wasting and, more recently, as a treatment for androgen-receptor-positive, ER-positive breast cancer, where it has reached phase 3.

This is an educational tracking guide, not a recommendation. Despite the clinical research, ostarine is not an approved drug, and the products sold to consumers are unapproved research chemicals that are frequently mislabeled.

What it is

• A non-steroidal compound that selectively activates the androgen receptor in muscle and bone
• Milder and more studied than most other SARMs
• Still suppressive of the body's own testosterone, especially at higher intakes or longer durations

Typical protocol shape

• Taken orally, once daily, over a defined block of weeks
• Doses and durations commonly reported in research literature; this guide does not prescribe one
• Often chosen for lean muscle retention rather than dramatic mass

What to track daily

• Bodyweight and training performance
• Energy, mood, and libido, which can drift as hormones shift
• Any joint or tendon discomfort

What to track weekly

• Strength progression on key lifts
• Waist and bodyweight trend
• Subjective sense of recovery between sessions

Bloodwork worth doing

• Total and free testosterone, LH and FSH before, during, and after
• A liver panel (ALT, AST)
• A lipid panel - SARMs commonly lower HDL

Realistic expectations

• Gains are real but modest compared with anabolic steroids
• Suppression is milder than stronger SARMs but not zero; many users plan for post-cycle recovery
• Product quality is the single biggest variable in real-world outcomes

Safety notes

Even the mildest SARM suppresses the HPTA, can lower HDL cholesterol, and can stress the liver. Because consumer products are unregulated, mislabeling and contamination are common and are a leading cause of unexpected side effects. Bloodwork before, during, and after, plus consideration of post-cycle therapy, is the sensible baseline for anyone who has decided to use it.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.